Abstract
The majority of patients with depression also will suffer from a comorbid anxiety disorder that may include panic disorder, obsessive-compulsive disorder, social phobia, or generalized anxiety disorder. The selective-serotonin reuptake inhibitors present an alternative and useful monotherapy in patients with depression and comorbid anxiety disorders. This treatment is likely to be highly cost-effective as well.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1047-1050 |
| Number of pages | 4 |
| Journal | American Journal of Managed Care |
| Volume | 2 |
| Issue number | 8 |
| State | Published - 1996 |
ASJC Scopus subject areas
- Health Policy